Your browser doesn't support javascript.
loading
Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.
Trivieri, Nadia; Visioli, Alberto; Mencarelli, Gandino; Cariglia, Maria Grazia; Marongiu, Laura; Pracella, Riccardo; Giani, Fabrizio; Soriano, Amata Amy; Barile, Chiara; Cajola, Laura; Copetti, Massimiliano; Palumbo, Orazio; Legnani, Federico; DiMeco, Francesco; Gorgoglione, Leonardo; Vescovi, Angelo L; Binda, Elena.
Afiliación
  • Trivieri N; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, 71013, San Giovanni Rotondo, FG, Italy.
  • Visioli A; StemGen SpA, Milan, Italy.
  • Mencarelli G; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, 71013, San Giovanni Rotondo, FG, Italy.
  • Cariglia MG; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, 71013, San Giovanni Rotondo, FG, Italy.
  • Marongiu L; Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
  • Pracella R; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, 71013, San Giovanni Rotondo, FG, Italy.
  • Giani F; StemGen SpA, Milan, Italy.
  • Soriano AA; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, 71013, San Giovanni Rotondo, FG, Italy.
  • Barile C; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, 71013, San Giovanni Rotondo, FG, Italy.
  • Cajola L; StemGen SpA, Milan, Italy.
  • Copetti M; Biostatistics Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Palumbo O; Medical Genetics Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Legnani F; Department of Neurosurgery, National Neurologic Institute IRCCS C. Besta, Milan, Italy.
  • DiMeco F; Department of Neurosurgery, National Neurologic Institute IRCCS C. Besta, Milan, Italy.
  • Gorgoglione L; Department of Neurosurgery, John Hopkins University, Baltimore, MD, USA.
  • Vescovi AL; Neurosurgery Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Binda E; Scientific Directorate, IRCCS Casa Sollievo della Sofferenza, FG, San Giovanni Rotondo, Italy. vescovia@gmail.com.
J Exp Clin Cancer Res ; 41(1): 139, 2022 Apr 12.
Article en En | MEDLINE | ID: mdl-35414102
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido